NCT04960683

Brief Summary

Need for study There are a few studies published on this topic from various parts of the globe and the results are mixed. Hence further research is required in this area and none of the studies have included samples from the Middle East. Some studies done in this area focus on biomechanical aspects of gait (Cherni, 2018) and our study mainly focuses on functional aspects of gait and quality of life. Studies done on this area focus highly on gait components and very little is available on the literature on improving balance. Since balance and stability are crucial for walking, it was decided to exclusively assess balance. Due to a wide range of therapeutic benefits, it is paramount to evaluate the effectiveness of different therapies provided to improve gait. Aim of the study: The aim of the proposed research is to investigate the effectiveness of robotic assisted gait training using Lokomat device as an adjunct in improving gait, balance and quality of life in children with cerebral palsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 13, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

July 14, 2021

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

March 25, 2022

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

January 13, 2021

Last Update Submit

March 24, 2022

Conditions

Keywords

ChildrenLokomat

Outcome Measures

Primary Outcomes (5)

  • Gross Motor Function Measure ( GMFM- 88) - dimension D & dimension E

    This is the validated test designed to measure change in gross motor function over time in children with cerebral palsy. Dimension D consist of 13 items for standing ability and dimension E has 24 items to assess walking, jumping and running in cerebral palsy children. Its a four point scoring system. Specific descriptors for each score is given in the Manual of GMFM-88.

    Baseline time 0 and up to 8 weeks

  • 6 minute Walk test

    The test has been selected as a measure of gait endurance. This is validated test requiring individuals to walk 6 minutes on flat hard floor. Scoring is walking distance.

    Baseline time 0 and up to 8 weeks

  • 10 meters Walk test

    The test has been selected as a measure of gait speed. This is validated test requiring individuals to walk on flat hard floor at their comfortable speed for 10 meters.

    Baseline time 0 and up to 8 weeks

  • Pediatric Balance Scale

    14 items valid scale is used to assess functional balance skills in children with spastic cerebral palsy.

    Baseline time 0 and up to 8 weeks

  • Cerebral Palsy Quality of Life questionnaire for child (CP QOL-child) and Cerebral Palsy Quality of Life questionnaire for adolescent (CP QOL- teen)

    This Arabic validated CP QOL- child for age 4-12 and CP QOL- teen for age 13-18 questionnaires are used in the parent version. Its assesses 7 domains on a 9 level point Likert scale.

    Baseline time 0 and up to 8 weeks

Secondary Outcomes (3)

  • Range of motion

    Baseline time 0 and up to 8 weeks

  • The Oxford scale

    Baseline time 0 and up to 8 weeks

  • Modified Ashworth Scale

    Baseline time 0 and up to 8 weeks

Study Arms (2)

Robotic -assisted gait training group using Lokomat device

EXPERIMENTAL

* 5 sessions of 40 minutes of conventional therapy and * 5 sessions of 40 minutes on Lokomat per week

Device: Lokomat training

Traditional therapy group

ACTIVE COMPARATOR

• 5 sessions of 40 minutes of conventional therapy

Device: Lokomat training

Interventions

Control group will receive the routine conventional physiotherapy treatment and the treatment for this group consists of the following: Conventional therapy protocol: * 5 sessions of 45 minutes a week, each session includes: * 5 minutes of stretching exercise * 20 minutes of strengthening exercise * 10 minutes of balance exercise * 10 minutes of gait training Experimental group will receive 45 min of Lokomat in addition to the conventional approach (as explained above). Since Lokomat appointments can be only 8 per day, it is planned to have two groups of 8 participants for 4 weeks each. The Lokomat training include the following: * 5 sessions of 45 minutes of conventional therapy (same as above) per week * 5 sessions of 45 minutes on Lokomat per week

Also known as: Conventional therapy
Robotic -assisted gait training group using Lokomat deviceTraditional therapy group

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Cerebral palsy with spastic and mix form
  • Gross Motor Function Classification System (GMFCS from level II to IV)
  • Age 4 to 18
  • No contraindications for the training in the Lokomat
  • Able to follow simple instructions

You may not qualify if:

  • On botox injection within the last 6 months (as the effect of botox wear out in 6 months)
  • Surgery within the last one year
  • Fixed contractures and/or with bone instability
  • Baclofen infusion pumps in situ
  • Seizure disorder that is not controlled by medication (if on medication, must not have had a seizure in the last 12 months);
  • Open skin lesions or vascular disorder of lower extremities;
  • Having participated in another Lokomat training regime within the previous 3months as well as a change in concomitant treatment within the last 4 weeks before or during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatima College of Health Sciences

Abu Dhabi, 3758, United Arab Emirates

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Dragana Djuric

    FCHS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor in physiotherapy

Study Record Dates

First Submitted

January 13, 2021

First Posted

July 14, 2021

Study Start

November 8, 2020

Primary Completion

July 31, 2021

Study Completion

December 31, 2021

Last Updated

March 25, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations